Literature DB >> 22503802

Uptake of a fluorescent methyl-β-cyclodextrin via clathrin-dependent endocytosis.

Anna Pia Plazzo1, Chris T Höfer, László Jicsinszky, Éva Fenyvesi, Lajos Szente, Jürgen Schiller, Andreas Herrmann, Peter Müller.   

Abstract

Cyclodextrins (CDs) are widely used both in pharmaceutical applications to improve drug bioavailability and in cell biology as cholesterol-depleting and -delivering agents. Recently, it was shown that β-CD covalently coupled to fluorescent dextran polymers accumulates in cholesterol-enriched lysosomal storage organelles of human fibroblasts (Rosenbaum et al., 2010). By employing a methyl-βCD tagged with fluorescein (FMβCD), we have characterized the cellular trafficking of the CD in mammalian cell lines and its distribution into the endocytic compartments within the first minutes following addition to cells. FMβCD enters mammalian cells via endocytosis. The colocalization of FMβCD with transferrin-containing endosomes and the inhibition of FMβCD internalization by chlorpromazine or by an antisense RNA against clathrin heavy chain indicate that FMβCD is taken up via receptor-mediated, clathrin-dependent endocytosis. These results not only highlight the possibility of using CDs to target drugs intracellularly, but also warn about potential unwanted effects on cell physiology other than cholesterol extraction/loading at high concentrations, high temperatures and prolonged incubation times.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22503802     DOI: 10.1016/j.chemphyslip.2012.03.007

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  15 in total

1.  Cyclodextrin mediates rapid changes in lipid balance in Npc1-/- mice without carrying cholesterol through the bloodstream.

Authors:  Anna M Taylor; Bing Liu; Yelenis Mari; Benny Liu; Joyce J Repa
Journal:  J Lipid Res       Date:  2012-08-14       Impact factor: 5.922

2.  Systemic administration of 2-hydroxypropyl-β-cyclodextrin to symptomatic Npc1-deficient mice slows cholesterol sequestration in the major organs and improves liver function.

Authors:  Adam M Lopez; Sandi J Terpack; Kenneth S Posey; Benny Liu; Charina M Ramirez; Stephen D Turley
Journal:  Clin Exp Pharmacol Physiol       Date:  2014-10       Impact factor: 2.557

3.  Cyclodextrin alleviates neuronal storage of cholesterol in Niemann-Pick C disease without evidence of detectable blood-brain barrier permeability.

Authors:  Charles C Pontikis; Cristin D Davidson; Steven U Walkley; Frances M Platt; David J Begley
Journal:  J Inherit Metab Dis       Date:  2013-02-15       Impact factor: 4.982

4.  Beta cyclodextrins bind, stabilize, and remove lipofuscin bisretinoids from retinal pigment epithelium.

Authors:  Marcelo M Nociari; Guillermo L Lehmann; Andres E Perez Bay; Roxana A Radu; Zhichun Jiang; Shelby Goicochea; Ryan Schreiner; J David Warren; Jufang Shan; Ségolène Adam de Beaumais; Mickaël Ménand; Matthieu Sollogoub; Frederick R Maxfield; Enrique Rodriguez-Boulan
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-24       Impact factor: 11.205

Review 5.  Niemann-Pick C disease and mobilization of lysosomal cholesterol by cyclodextrin.

Authors:  Jean E Vance; Barbara Karten
Journal:  J Lipid Res       Date:  2014-03-24       Impact factor: 5.922

6.  Fluorescently labeled methyl-beta-cyclodextrin enters intestinal epithelial Caco-2 cells by fluid-phase endocytosis.

Authors:  Ferenc Fenyvesi; Katalin Réti-Nagy; Zsolt Bacsó; Zsuzsanna Gutay-Tóth; Milo Malanga; Éva Fenyvesi; Lajos Szente; Judit Váradi; Zoltán Ujhelyi; Pálma Fehér; Gábor Szabó; Miklós Vecsernyés; Ildikó Bácskay
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

7.  2-Hydroxypropyl-β-cyclodextrin reduces retinal cholesterol in wild-type and Cyp27a1-/- Cyp46a1-/- mice with deficiency in the oxysterol production.

Authors:  Nicole El-Darzi; Natalia Mast; Alexey M Petrov; Irina A Pikuleva
Journal:  Br J Pharmacol       Date:  2020-08-13       Impact factor: 8.739

8.  CD147 monoclonal antibody mediated by chitosan nanoparticles loaded with α-hederin enhances antineoplastic activity and cellular uptake in liver cancer cells.

Authors:  Rong Zhu; Chun-ge Zhang; Yang Liu; Zhi-qiang Yuan; Wei-liang Chen; Shu-di Yang; Ji-zhao Li; Wen-jing Zhu; Xiao-feng Zhou; Ben-gang You; Xue-nong Zhang
Journal:  Sci Rep       Date:  2015-12-07       Impact factor: 4.379

9.  2-Hydroxypropyl-β-Cyclodextrin Acts as a Novel Anticancer Agent.

Authors:  Masako Yokoo; Yasushi Kubota; Keiichi Motoyama; Taishi Higashi; Masatoshi Taniyoshi; Hiroko Tokumaru; Rena Nishiyama; Yoko Tabe; Sakiko Mochinaga; Akemi Sato; Naoko Sueoka-Aragane; Eisaburo Sueoka; Hidetoshi Arima; Tetsumi Irie; Shinya Kimura
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

10.  New synthetic strategies for xanthene-dye-appended cyclodextrins.

Authors:  Milo Malanga; Andras Darcsi; Mihaly Balint; Gabor Benkovics; Tamas Sohajda; Szabolcs Beni
Journal:  Beilstein J Org Chem       Date:  2016-03-17       Impact factor: 2.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.